Meitav Dash Investments LTD Neuro Sense Therapeutics Ltd. Transaction History
Meitav Dash Investments LTD
- $4.92 Billion
- Q1 2024
A detailed history of Meitav Dash Investments LTD transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Meitav Dash Investments LTD holds 50,000 shares of NRSN stock, worth $42,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,000
Previous 95,000
47.37%
Holding current value
$42,500
Previous $74,000
22.97%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NRSN
# of Institutions
9Shares Held
167KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny71.1KShares$60,4350.0% of portfolio
-
Woodline Partners LP San Francisco, CA19.6KShares$16,6430.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12KShares$10,1680.0% of portfolio
-
Ubs Group Ag11.9KShares$10,1380.0% of portfolio
-
Morgan Stanley New York, NY1.5KShares$1,2750.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $9.92M